Information  X 
Enter a valid email address

Judges ScientificPLC (JDG)

  Print          Annual reports

Thursday 09 June, 2022

Judges ScientificPLC

Issue of Shares - Replacement

RNS Number : 2938O
Judges Scientific PLC
09 June 2022

The following replaces the announcement released on 08 June 2022 at 15:52 under RNS No 2075O.

The previous announcement incorrectly stated Mr Holroyd's holding as a percentage of the issued share capital of the Company. The full amended text is shown below.



Judges Scientific plc


("Judges Scientific" or the "Company")


Issue of Ordinary Shares


Further to the announcement of the acquisition of Geotek on 23 May 2022 ("Geotek Announcement"), Judges Scientific has today issued 2,929 ordinary shares of 5p each ("Ordinary Share") to Charles Holroyd, Non Executive Director of the Company, as payment for the Introduction Fee due to him in relation to the Initial Consideration for Geotek.

Following the issue of shares, Mr Holroyd now holds 4,945 Ordinary Shares representing 0.1 % of the total issued share capital and voting rights in the Company.

Application for admission of the new Ordinary Shares to trading on AIM has been made and dealing in the new Ordinary Shares is expected to commence at 8.00 a.m. on 13 June 2022. The new Ordinary Shares will rank pari-passu with the Company's existing issued ordinary shares.

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meaning as in the Geotek Announcement.


Ends -  

For further information please contact:

Judges Scientific



David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970


Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090


Liberum (Joint Broker)

Edward Mansfield

William Hall


Media enquiries:

Alma PR (Financial Public Relations)


Tel : +44 (0) 20 3100 2222


Sam Modlin

Justine James

Joe Pederzolli


Tel: +44 (0) 20 3405 0205

[email protected]


Notes to editors:  

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group now consists of 20 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit





Details of the person discharging managerial responsibilities / person closely associated







Charles Holroyd



Reason for the notification







Non Executive Director



Initial notification /Amendment



Initial notification



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor







Judges Scientific plc









Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




Description of the financial instrument, type of instrument


Identification code


Ordinary shares in Judges Scientific plc







Nature of the transaction



Issue of shares in payment of an introduction fee in relation to a transaction by the Company



Price(s) and volume(s)













Aggregated information


- Aggregated volume


- Price


N/A (single transaction)



Date of the transaction






Place of the transaction



London Stock Exchange, AIM Market (XLON)


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t